HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.

Abstract
Excessive activation of NLRP3 inflammasome is associated with the pathogenesis of inflammatory diseases. Pristimerin (Pri) is a quinonoid triterpene derived from traditional Chinese medical herb Celastraceae and Hippocrateaceae. Pri has shown antifungal, antibacterial, antioxidant, and anticancer activities. In this study we investigated whether NLRP3 inflammasome was associated with the anti-inflammatory activity of Pri. We showed that Pri (0.1-0.4 μM) dose-dependently blocked caspase-1 activation and IL-1β maturation in LPS-primed mouse bone-marrow-derived macrophages (BMDMs). Pri specifically inhibited NLRP3 inflammasome activation, had no visible effects on NLRC4 and AIM2 inflammasome activation. Furthermore, we demonstrated that Pri blocked the assembly of the NLRP3 inflammasome via disturbing the interaction between NEK7 and NLRP3; the α, β-unsaturated carbonyl moiety of Pri was essential for NLRP3 inflammasome inactivation. In LPS-induced systemic inflammation mouse model and MSU-induced mouse peritonitis model, preinjection of Pri (500 μg/kg, ip) produced remarkable therapeutic effects via inhibition of NLRP3 inflammasome in vivo. In HFD-induced diabetic mouse model, administration of Pri (100 μg· kg-1 ·d-1, ip, for 6 weeks) reversed HFD-induced metabolic disorders via suppression of NLRP3 inflammasome activation. Taken together, our results demonstrate that Pri acts as a NLRP3 inhibitor, suggesting that Pri might be useful for the treatment of NLRP3-associated diseases.
AuthorsQun Zhao, Yun Bi, Jian Guo, Ying-Xiang Liu, Jing Zhong, Long-Rui Pan, Yan Tan, Xian-Jun Yu
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 42 Issue 6 Pg. 975-986 (Jun 2021) ISSN: 1745-7254 [Electronic] United States
PMID32989235 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Inflammasomes
  • Lipopolysaccharides
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Pentacyclic Triterpenes
  • Uric Acid
  • celastrol methyl ester
Topics
  • Animals
  • Anti-Inflammatory Agents (therapeutic use)
  • Cells, Cultured
  • Inflammasomes (antagonists & inhibitors)
  • Inflammation (chemically induced, prevention & control)
  • Lipopolysaccharides
  • Liver (pathology)
  • Male
  • Metabolic Diseases (pathology, prevention & control)
  • Mice, Inbred C57BL
  • NLR Family, Pyrin Domain-Containing 3 Protein (antagonists & inhibitors)
  • Pentacyclic Triterpenes (therapeutic use)
  • Peritonitis (chemically induced, prevention & control)
  • Uric Acid
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: